Cash Flow Sisram Medical Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
220.00
253.00
293.00
350.00
326.00
129.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-233.00
-75.00
-53.00
-322.00
-170.00
-26.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
74.00
265.00
346.00
174.00
259.00
202.00
Cash Flow from Investing Activities
-20.00
-137.00
-239.00
-580.00
-499.00
-71.00
Cash Flow from Financing Activities
-79.00
-123.00
-160.00
-136.00
523.00
-91.00
Net Cash Inflow / Outflow
5.00
-2.00
-85.00
-559.00
284.00
66.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
30.00
-6.00
-33.00
-17.00
1.00
28.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Sisram Medical Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
220.939771403603
280.790692343683
-60.00
-21.32%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-233.959158074176
7.49731006180551
-240.00
-3220.57%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
74.483365419549
379.626560687748
-305.00
-80.38%
Cash Flow from Investing Activities
-20.1293750798908
-547.748289093799
527.00
96.33%
Cash Flow from Financing Activities
-79.4728309699482
293.249696826544
-372.00
-127.10%
Net Cash Inflow / Outflow
5.64433290388881
117.944085612827
-112.00
-95.21%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
30.7631735341785
-7.18388280766667
37.00
528.22%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is -71.90% vs -23.57% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
74.48
265.10
-71.90%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
